135 related articles for article (PubMed ID: 15908830)
1. Stimulant-atypical antipsychotic interaction and acute dystonia.
Benjamin E; Salek S
J Am Acad Child Adolesc Psychiatry; 2005 Jun; 44(6):510-2. PubMed ID: 15908830
[No Abstract] [Full Text] [Related]
2. Aripiprazole induced acute dystonia after discontinuation of a stimulant medication.
McLaren JL; Cauble S; Barnett RJ
J Clin Psychopharmacol; 2010 Feb; 30(1):77-8. PubMed ID: 20075654
[No Abstract] [Full Text] [Related]
3. Acute dyskinesia on starting methylphenidate after risperidone withdrawal.
Hollis CP; Thompson A
Pediatr Neurol; 2007 Oct; 37(4):287-8. PubMed ID: 17903675
[TBL] [Abstract][Full Text] [Related]
4. Naturalistic long-term use of methylphenidate in bipolar disorder.
Lydon E; El-Mallakh RS
J Clin Psychopharmacol; 2006 Oct; 26(5):516-8. PubMed ID: 16974196
[TBL] [Abstract][Full Text] [Related]
5. Stimulants for ADHD in child patients with Tourette's syndrome: the issue of relative risk.
Gadow KD; Sverd J
J Dev Behav Pediatr; 1990 Oct; 11(5):269-71; discussion 272. PubMed ID: 1979565
[No Abstract] [Full Text] [Related]
6. Stimulant dosing in the community treatment of adult attention-deficit/hyperactivity disorder.
Olfson M; Marcus SC; Zhang HF; Wan GJ
J Clin Psychopharmacol; 2008 Apr; 28(2):255-7. PubMed ID: 18344749
[No Abstract] [Full Text] [Related]
7. Risperidone-to-methylphenidate switch reaction in children: three cases.
Sabuncuoglu O
J Psychopharmacol; 2007 Mar; 21(2):216-9. PubMed ID: 17329303
[TBL] [Abstract][Full Text] [Related]
8. Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: effects of stimulant and dose.
Castellanos FX; Giedd JN; Elia J; Marsh WL; Ritchie GF; Hamburger SD; Rapoport JL
J Am Acad Child Adolesc Psychiatry; 1997 May; 36(5):589-96. PubMed ID: 9136492
[TBL] [Abstract][Full Text] [Related]
9. Acute dystonic reaction in an adolescent on risperidone when a concomitant stimulant medication is discontinued.
Keshen A; Carandang C
J Child Adolesc Psychopharmacol; 2007 Dec; 17(6):867-70. PubMed ID: 18315457
[TBL] [Abstract][Full Text] [Related]
10. Not just another antipsychotic-for-conduct-problems trial.
Blader JC
J Am Acad Child Adolesc Psychiatry; 2014 Jan; 53(1):17-20. PubMed ID: 24342382
[No Abstract] [Full Text] [Related]
11. Quetiapine in treatment-resistant obsessive-compulsive disorder.
Cohen LS
J Am Acad Child Adolesc Psychiatry; 2003 Jun; 42(6):623-4. PubMed ID: 12921466
[No Abstract] [Full Text] [Related]
12. Ritalin is okay for kids with both ADHD and Tourette's syndrome, study says.
Levenson D
Rep Med Guidel Outcomes Res; 2002 Mar; 13(6):5-7. PubMed ID: 12449103
[No Abstract] [Full Text] [Related]
13. The use of imipramine in Tourette's syndrome and attention deficit disorder: case report.
Dillon DC; Salzman IJ; Schulsinger DA
J Clin Psychiatry; 1985 Aug; 46(8):348-9. PubMed ID: 2862138
[TBL] [Abstract][Full Text] [Related]
14. The stimulants.
Wilens TE; Biederman J
Psychiatr Clin North Am; 1992 Mar; 15(1):191-222. PubMed ID: 1347939
[TBL] [Abstract][Full Text] [Related]
15. Stimulants and neuroleptic withdrawal dyskinesia.
Connor DF
J Am Acad Child Adolesc Psychiatry; 1998 Mar; 37(3):247-8. PubMed ID: 9519625
[No Abstract] [Full Text] [Related]
16. Methylphenidate transdermal system.
Mays DA; Findling R
J Am Acad Child Adolesc Psychiatry; 2005 Dec; 44(12):1223. PubMed ID: 16292112
[No Abstract] [Full Text] [Related]
17. Recognition and treatment of attention deficit disorder.
Bond WS
Clin Pharm; 1987 Aug; 6(8):617-24. PubMed ID: 2891464
[TBL] [Abstract][Full Text] [Related]
18. Clinical inquiries. Does increasing methylphenidate dose aid symptom control in ADHD?
Ibay AD; Bascelli LM; Graves RS; Hill J
J Fam Pract; 2003 May; 52(5):400, 403. PubMed ID: 12737774
[No Abstract] [Full Text] [Related]
19. Emergence of tics in children with attention deficit hyperactivity disorder treated with stimulant medications.
Varley CK; Vincent J; Varley P; Calderon R
Compr Psychiatry; 2001; 42(3):228-33. PubMed ID: 11349243
[TBL] [Abstract][Full Text] [Related]
20. Effect of methylphenidate on the quality of life in children with epilepsy and attention deficit hyperactivity disorder: and open-label study using an osmotic-controlled release oral delivery system.
Yoo HK; Park S; Wang HR; Lee JS; Kim K; Paik KW; Yum MS; Ko TS
Epileptic Disord; 2009 Dec; 11(4):301-8. PubMed ID: 20007067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
